Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01795924. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Versus Low Frequency rTMS on Motor Dysfunction in PD
ClinicalTrials.gov study NCT03342846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT03182803. IPD Sharing: NO. Countries: 1. Publications: 0.
PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)
ClinicalTrials.gov study NCT02485327. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
ClinicalTrials.gov study NCT05927142. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06868277. IPD Sharing: YES. Countries: 27. Publications: 0.
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogen
ClinicalTrials.gov study NCT06938867. IPD Sharing: NO. Countries: 1. Publications: 0.
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
ClinicalTrials.gov study NCT01067287. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
ClinicalTrials.gov study NCT05763004. IPD Sharing: NO. Countries: 1. Publications: 0.
The Immune Assessment of PD-1 Antibody Therapy in Tumor
ClinicalTrials.gov study NCT06693440. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors
ClinicalTrials.gov study NCT00949559. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX
ClinicalTrials.gov study NCT03134456. IPD Sharing: NO. Countries: 1. Publications: 0.
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
ClinicalTrials.gov study NCT06056895. IPD Sharing: NO. Countries: 1. Publications: 0.
Objective Assessment of Behavioural Disorders in PD
ClinicalTrials.gov study NCT04611581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer
ClinicalTrials.gov study NCT04357587. IPD Sharing: YES. Countries: 1. Publications: 0.
Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease
ClinicalTrials.gov study NCT05308238. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04030260. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants
ClinicalTrials.gov study NCT01106469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
ClinicalTrials.gov study NCT06946641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients Wi
ClinicalTrials.gov study NCT07373964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.